Cambridge Investment Research Advisors’s Hyliion Holdings HYLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$75K Buy
14,451
+830
+6% +$3.45K ﹤0.01% 3951
2026
Q1
$24K Hold
13,621
﹤0.01% 3886
2025
Q4
$25K Buy
13,621
+1,000
+8% +$2.01K ﹤0.01% 3784
2025
Q3
$25K Buy
12,621
+500
+4% +$832 ﹤0.01% 3683
2025
Q2
$16K Buy
+12,121
New +$17.7K ﹤0.01% 3585
2021
Q2
Sell
-25,867
Closed -$276K 3133
2021
Q1
$276K Sell
25,867
-10,982
-30% -$172K ﹤0.01% 2340
2020
Q4
$607K Buy
36,849
+9,710
+36% +$221K ﹤0.01% 1642
2020
Q3
$1.35M Buy
27,139
+5,489
+25% +$180K 0.01% 1011
2020
Q2
$594K Buy
+21,650
New +$262K ﹤0.01% 1458

Other funds holding HYLN

Cambridge Investment Research Advisors's HYLN Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its Hyliion Holdings (HYLN) stake by 6.1% in Q2 2026, buying an estimated $3.45K and bringing the position to 14,451 shares worth $75K. The position accounts for ﹤0.01% of the portfolio, ranked #3951.

Cambridge Investment Research Advisors first reported a position in HYLN in Q2 2020 and has held it in 9 quarters since. The position peaked at $1.35M in Q3 2020. 36 funds tracked by Wall St. Rank hold HYLN as of Q2 2026.

  • Cambridge Investment Research Advisors held 14,451 shares of Hyliion Holdings worth $75K as of Q2 2026.
  • Cambridge Investment Research Advisors bought 830 Hyliion Holdings shares in Q2 2026, an estimated $3.45K.
  • Hyliion Holdings made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3951 holding.
  • Cambridge Investment Research Advisors first reported a position in Hyliion Holdings in Q2 2020 and has held it in 9 quarters since.
  • Cambridge Investment Research Advisors's Hyliion Holdings position peaked at $1.35M in Q3 2020.
  • 36 funds tracked by Wall St. Rank held Hyliion Holdings as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.